medigraphic.com
SPANISH

Revista Mexicana de Anestesiología

ISSN 3061-8142 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • Policies
    • Políticas éticas
    • Políticas editoriales generales
    • Políticas de revisión de manuscritos
    • Políticas de acceso abierto
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2026, Number S1

<< Back Next >>

Rev Mex Anest 2026; 49 (S1)

Metabolic control in kidney transplantation: electrolyte and acid-base imbalances

Romero-Betancourt WA
Full text How to cite this article

Language: Spanish
References: 15
Page: 202-204
PDF size: 774.32 Kb.


Key words:

No keywords

Text Extraction

No abstract.


REFERENCES

  1. Bouquegneau A, Salam S, Delanaye P, Eastell R, Khwaja A. Bone diseaseafter kidney transplantation. Clin J Am Soc Nephrol. 2016;11:1282-1296.

  2. Dienemann T, Ziolkowski SL, Bender S, Goral S, Long J, Baker JF, etal. Changes in body composition, muscle strength, and fat distributionfollowing kidney transplantation. Am J Kidney Dis. 2021;78:816-825.

  3. Schneider S, Biggerstaff D, Barber TM. Dietary guidelines post kidneytransplant: is this the missing link in recovery and graft survival? TransplInt. 2025;38:14288.

  4. do Nascimento Junior P, Dohler LE, Ogawa CMU, de Andrade LÍGM,Braz LG, M Dolo NSP. Effects of Plasma-Lyte.® and 0.9% saline inrenal function after deceased-donor kidney transplant: a randomizedcontrolled trial. Braz J Anesthesiol. 2022;72:711-719.

  5. Iqbal A, Zhou K, Kashyap SR, Lansang MC. Early post-renal transplanthyperglycemia. J Clin Endocrinol Metab. 2022;107:549-562.

  6. Song CC, Brown A, Winstead R, Yakubu I, Demehin M, Kumar D, et al.Early initiation of sodium-glucose linked transporter inhibitors (SGLT-2i) and associated metabolic and electrolyte outcomes in diabetic kidneytransplant recipients. Endocrinol Diabetes Metab. 2020;4:e00185.

  7. Aleksandar T, Gordana Z, Slavica S, Ivan M. Transplanted kidneyincreases nitric oxide formation with metabolic acidosis reduction. ExpClin Transplant. 2020;18:450-457.

  8. Damasiewicz MJ, Ebeling PR. Management of mineral and bonedisorders in renal transplant recipients. Nephrology (Carlton).2017;22:65-69.

  9. Baloglu I, Ozer H, Ozturk Y, Erdur MF, Tonbul HZ, Turkmen K. Therelationship between FGF23 and anemia in HD and renal transplantpatients. Int Urol Nephrol. 2022;54:1117-1122.

  10. Sá H, Leal R, Rosa MS. Renal transplant immunology in the last 20years: a revolution towards graft and patient survival improvement. IntRev Immunol. 2017;36:182-203.

  11. Sabbatini M, Ferreri L, Pisani A, Capuano I, Morgillo M, Memoli A, etal. Nutritional management in renal transplant recipients: a transplantteam opportunity to improve graft survival. Nutr Metab Cardiovasc Dis.2019;29:319-324.

  12. Rosenberger C, Eckardt KU. Oxygenation of the transplanted kidney.Semin Nephrol. 2019;39:554-566.

  13. Reiterer C, Hu K, Sljivic S, Falkner von Sonnenburg M, FleischmannE, Kainz A, et al. Mannitol and renal graft injury in patients undergoingdeceased donor renal transplantation – a randomized controlled clinicaltrial. BMC Nephrol. 2020;21:307.

  14. Li G, Hou Y, Zhang L, Chen L, Yang Y, Yu D. Gut microbiota andmetabolomic profiles of tacrolimus-induced DILI in renal transplantrecipients. BMC Microbiol. 2025;25:684.

  15. Parajuli S, Lockridge JB, Langewisch ED, Norman DJ, Kujovich JL.Hypercoagulability in kidney transplant recipients. Transplantation.2016;100:719-726.




CC BY-NC-ND

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Anest. 2026;49